Granja, Jeffrey M.
Klemm, Sandy http://orcid.org/0000-0001-7556-6795
McGinnis, Lisa M.
Kathiria, Arwa S.
Mezger, Anja
Corces, M. Ryan
Parks, Benjamin http://orcid.org/0000-0002-0261-7472
Gars, Eric
Liedtke, Michaela
Zheng, Grace X. Y. http://orcid.org/0000-0002-5006-3785
Chang, Howard Y. http://orcid.org/0000-0002-9459-4393
Majeti, Ravindra
Greenleaf, William J. http://orcid.org/0000-0003-1409-3095
Funding for this research was provided by:
American Society of Hematology Scholars
Ludwig Cancer Research
Chan Zuckerberg Investigator
Article History
Received: 30 April 2019
Accepted: 29 October 2019
First Online: 2 December 2019
Competing interests
: R.M. is a founder of, is an equity holder in, and serves on the board of directors of Forty Seven. H.Y.C. has affiliations with Accent Therapeutics (founder and scientific advisory board (SAB) member), 10x Genomics (SAB member), Boundless Bio (cofounder, SAB), Arsenal Biosciences (SAB) and Spring Discovery (SAB member). W.J.G. has affiliations with 10x Genomics (consultant), Guardant Health (consultant) and Protillion Biosciences (co-founder and consultant).